NCT00674661 - Corneal Collagen Cross-Linking for Ectasia (CXL) | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Ectasia

Interventions

DRUG

riboflavin ophthalmic solution

riboflavin 0.1% ophthalmic solution (approximately 32 drops, or 1.6 mL)

DEVICE

UVA Irradiation

UVA light (365 nm at an irradiance of 3 mW/cm2) for 30 minutes

Trial Locations (10)

Edward Harkness Eye Institute at Columbia University Medical Center, New York

Ophthalmic Consultants of Long Island, Rockville Centre

Wilmer Eye Institute at Johns Hopkins University, Baltimore

Center for Excellence in Eye Care, Miami

Price Vision Group, Indianapolis

Minnesota Eye Consultants, Minneapolis

Durrie Vision, Kansas City

Gordon -Weiss Vision Institute, San Diego

Shiley Eye Center, La Jolla

Cornea & Laser Eye Institute; Hersh Vision Group, Teaneck